Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 16, 2023; 11(26): 6289-6297
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6289
Published online Sep 16, 2023. doi: 10.12998/wjcc.v11.i26.6289
Item | Detection value | Unit | Normal range |
White blood cell count | 8.25 | ×109/L | 3.50-9.50 |
Red cell count | 3.80 | ×1012/L | 3.80-5.10 |
Hemoglobin | 98 | g/L | 115-150 |
Platelet count | 163 | ×109/L | 125-350 |
Lymphocyte proportion | 5.2 | % | 20.0-50.0 |
Lymphocyte count | 0.43 | ×109/L | 1.10-3.20 |
Alanine aminotransferase | 5 | U/L | 7-40 |
Total bilirubin | 30.8 | µmol/L | 3.4-22.2 |
Direct bilirubin | 10.8 | µmol/L | 0.0-3.4 |
Indirect bilirubin | 20.0 | µmol/L | 3.4-18.8 |
Serum sodium | 133.1 | mmol/L | 137.0-147.0 |
Serum calcium | 1.88 | mmol/L | 2.10-2.60 |
Cystatin C | 1.40 | mg/L | 0.51-1.09 |
β-Hydroxybutyric acid | 0.56 | mmol/L | 0.02-0.30 |
High-density lipoprotein cholesterol | 0.65 | mmol/L | 0.80-1.96 |
Apolipoprotein A1 | 0.74 | g/L | 1.00-1.60 |
Apolipoprotein E | 51.7 | mg/L | 27.0-49.0 |
Prealbumin | 0.06 | g/L | 0.18-0.40 |
Total protein | 48.2 | g/L | 65.0-85.0 |
Albumin | 23.8 | g/L | 40.0-55.0 |
Albumin–globulin ratio | 1.0 | 1.2-2.4 | |
Phosphocreatine kinase | 20 | U/L | 26-174 |
Lactate dehydrogenase | 538 | U/L | 108-252 |
Highly sensitive C-reactive protein | 104.30 | mg/L | 0.00-3.00 |
Cholinesterase | 2730 | U/L | 5300-12900 |
Leucylaminopeptidase | 17.5 | U/L | 20.0-60.0 |
Retinol binding protein | 15.0 | mg/L | 25.0-70.0 |
Serum iron | 4.1 | µmol/L | 7.0-32.0 |
Total iron binding capacity | 23.0 | µmol/L | 45.0-75.0 |
Unsaturated iron binding capacity | 18.9 | µmol/L | 31.0-51.0 |
Transferrin | 1.27 | g/L | 1.90-3.80 |
Adenosine deaminase | 21.1 | U/L | 0.0-15.0 |
Superoxide dismutase | 94 | U/mL | 129-216 |
Carcinoembryonic antigen | 1.5 | ng/mL | ≤ 5 |
Alpha-fetoprotein | 1.6 | ng/mL | ≤ 25 |
Carbohydrate antigen 72-4 | 2.8 | U/mL | ≤ 7 |
Carbohydrate antigen 125 | 109.3 | U/mL | ≤ 35 |
Carbohydrate antigen 19-9 | 40.5 | U/mL | ≤ 34 |
- Citation: Jiang M, Yuan XP. Collision tumor of primary malignant lymphoma and adenocarcinoma in the colon diagnosed by molecular pathology: A case report and literature review. World J Clin Cases 2023; 11(26): 6289-6297
- URL: https://www.wjgnet.com/2307-8960/full/v11/i26/6289.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i26.6289